Show simple item record

dc.contributor.authorLavitas, Pavel
dc.contributor.authorLenz, Kimberly J.
dc.contributor.authorHydery, Tasmina
dc.contributor.authorTesell, Mark
dc.contributor.authorGagnon, J.
dc.contributor.authorJeffrey, Paul L.
dc.date2022-08-11T08:08:06.000
dc.date.accessioned2022-08-23T15:42:30Z
dc.date.available2022-08-23T15:42:30Z
dc.date.issued2014-10-07
dc.date.submitted2017-11-07
dc.identifier.doi10.13028/vz23-vh76
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26862
dc.description<p>Presented at the Academy of Managed Care Pharmacy’s Nexus 2014.</p>
dc.description.abstractThis presentation outlines a successful hepatitis C medication monitoring program instituted by Clinical Pharmacy Services for MassHealth, the Massachusetts Medicaid program. The program used outreach and education strategies to communicate with prescribers about regimens that were the most effective in treating the virus and containing costs. Member adherence to the regimen was monitored and hepatitis C cure rates were tracked through the program.
dc.language.isoen_US
dc.subjectHepatitis C
dc.subjectmedication management
dc.subjectMedicaid
dc.subjectMassHealth
dc.subjectMassachusetts
dc.subjectHealth Economics
dc.subjectHealth Law and Policy
dc.subjectHealth Policy
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectVirus Diseases
dc.titleOverview of a Hepatitis C Medication Monitoring Program in a State Medicaid Program
dc.typePresentation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1089&amp;context=commed_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/commed_pubs/100
dc.identifier.contextkey11009442
refterms.dateFOA2022-08-23T15:42:30Z
html.description.abstract<p>This presentation outlines a successful hepatitis C medication monitoring program instituted by Clinical Pharmacy Services for MassHealth, the Massachusetts Medicaid program. The program used outreach and education strategies to communicate with prescribers about regimens that were the most effective in treating the virus and containing costs. Member adherence to the regimen was monitored and hepatitis C cure rates were tracked through the program.</p>
dc.identifier.submissionpathcommed_pubs/100
dc.contributor.departmentCommonwealth Medicine, Office of Clinical Affairs
dc.contributor.departmentCommonwealth Medicine, Clinical Pharmacy Services


Files in this item

Thumbnail
Name:
8922_Overview_of_a_Hepatitis_C ...
Size:
275.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record